Saturday, September 13, 2025
  • Advertise
  • Recruitment
  • Contact us:
  • Register
Irish Pharmacy News
  • News
    • Latest
    • Community Pharmacy
  • Learning
    • CPD
    • Features
    • Team Training
    • Research
  • Magazines
  • OTC
    • OTC Awards
    • Product News
  • Awards
    • Irish Pharmacy Awards 2024
    • Awards News
  • HPN
  • Log In
  • Register
No Result
View All Result
  • News
    • Latest
    • Community Pharmacy
  • Learning
    • CPD
    • Features
    • Team Training
    • Research
  • Magazines
  • OTC
    • OTC Awards
    • Product News
  • Awards
    • Irish Pharmacy Awards 2024
    • Awards News
  • HPN
  • Log In
  • Register
No Result
View All Result
Irish Pharmacy News

Next Phase of High Tech Hub

IPN by IPN
13 June 2019
in Developments
0

The next phase of the High Tech Hub was due to roll out at the start of this month (1st June). This will include Rheumatology, Dermatology and Gastroenterology. IVF, PAH and Cystic Fibrosis medicines are currently ordered through the Hub.

In the case of three products – Idebenone (Raxone®) and Ataluren (Translarna®), which have been available through the Hub since 1 May, and Dimethyl Fumerate (Skilarence®), which will be included for ordering through the Hub from 1 June – the HSE is adopting a zero tolerance approach. If prescriptions for these products are not generated through the Hub, the medicine cannot be ordered by the pharmacy and the High Tech fee cannot be claimed. Prescribers must input prescriptions for these products directly on to the High Tech Hub to ensure the patients meet the reimbursement criteria.

The HSE has advised us that they have engaged with the relevant consultant prescribers in relation to this and that the prescribers are aware of the requirement to input prescriptions for these products directly onto the High Tech Hub. High Tech prescription forms generated on the Hub are prefaced by ‘HTH’. For Skilarence, a High Tech Hub prescription only needs to be generated on the Hub for newly initiated patients.

The contact details for the High Tech Hub are pcrs.hitech@hse.ie / 01 864 7135. The FAQs and User Guide are available on the Help section of the High Tech Hub. Patients with concerns can contact the HSE at hselive@hse.ie or phone 041 685 0300 or 1850 241 850.

No doubt there will be some problems with the change to these services from 1 June. If you have any questions or comments on centralisation of the LTI Scheme or on the High Tech Hub, contact Derek or Aoife in the Contract Unit on aoife.garrigan@ipu.ie or call 01 406 1557. We will be raising all issues and concerns with the HSE in order to have them resolved.

Previous Post

Get Breathless for COPD Cycle

Next Post

Taoiseach and Ministers for Health announce €450K funding boost to HIV

Next Post

Taoiseach and Ministers for Health announce €450K funding boost to HIV

McCabes Pharmacy launches nationwide flu vaccination service as research shows parents hit hard by flu

McCabes Pharmacy launches nationwide flu vaccination service as research shows parents hit hard by flu

11 September 2025
Four UCD researchers receive ERC Starting Grants for groundbreaking research projects

Four UCD researchers receive ERC Starting Grants for groundbreaking research projects

4 September 2025
EUROPEAN COMMISSION AUTHORISES TWICE-YEARLY LENACAPAVIR FOR HIV  PREVENTION (brand name YEYTUO®) 

EUROPEAN COMMISSION AUTHORISES TWICE-YEARLY LENACAPAVIR FOR HIV  PREVENTION (brand name YEYTUO®) 

4 September 2025

RECOMMENDED NEWS

Nolan sisters get behind Irish Cancer Society’s most important Daffodil Day ever

Nolan sisters get behind Irish Cancer Society’s most important Daffodil Day ever

5 years ago
Glow Masks is a new Irish wellness brand

Glow Masks is a new Irish wellness brand

4 years ago
New Irish Supplement to Support Immunity and tackle D-ficiency

New Irish Supplement to Support Immunity and tackle D-ficiency

5 years ago
Major international trial finds cooling critical patients’ body temperature after cardiac arrest does not improve survival

Major international trial finds cooling critical patients’ body temperature after cardiac arrest does not improve survival

4 years ago
Tweets by Irish_PharmNews

Quick links

  • About
  • Advertise
  • Careers
  • Contact us

Other info

  • Contact us
  • Register for Digital Magazines
  • Privacy Policy
  • About
  • Advertise
  • Careers
  • Contact us

© 2024 IPN

  • Login

    Forgot password? | Register

    Register

    Registration confirmation will be emailed to you.

    Login | Forgot password?

    Reset Password

    Please enter your username or email address. You will receive a link to create a new password via email.

    Login

Login

Register

Forgotten Password?

Register | Lost your password?
| Back to Login
No Result
View All Result
  • News
  • Learning
  • Other
    • Conferencing
    • Developments
    • Product News
    • Profiles
    • Research
  • Digital Magazines (IPN Online Issues Older Issue Tabs)
  • Awards

© 2024 IPN